BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23225254)

  • 1. Polymorphisms of TNF and IL-10 genes and clinical outcome of patients with chronic lymphocytic leukemia.
    Lech-Maranda E; Mlynarski W; Grzybowska-Izydorczyk O; Borowiec M; Pastorczak A; Cebula-Obrzut B; Klimkiewicz-Wojciechowska G; Wcislo M; Majewski M; Kotkowska A; Robak T; Warzocha K
    Genes Chromosomes Cancer; 2013 Mar; 52(3):287-96. PubMed ID: 23225254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum tumor necrosis factor-α and interleukin-10 levels as markers to predict outcome of patients with chronic lymphocytic leukemia in different risk groups defined by the IGHV mutation status.
    Lech-Maranda E; Grzybowska-Izydorczyk O; Wyka K; Mlynarski W; Borowiec M; Antosik K; Cebula-Obrzut B; Makuch-Lasica H; Nowak G; Klimkiewicz-Wojciechowska G; Wawrzyniak E; Bilinski P; Robak T; Warzocha K
    Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):477-86. PubMed ID: 22945689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia.
    Ennas MG; Moore PS; Zucca M; Angelucci E; Cabras MG; Melis M; Gabbas A; Serpe R; Madeddu C; Scarpa A; Cocco P
    Hematol Oncol; 2008 Jun; 26(2):98-103. PubMed ID: 18271063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia.
    Xie C; Yao MZ; Liu JB; Xiong LK
    Cytokine; 2011 Dec; 56(3):550-9. PubMed ID: 22019000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
    Cheong JY; Cho SW; Hwang IL; Yoon SK; Lee JH; Park CS; Lee JE; Hahm KB; Kim JH
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 10 and tumor necrosis factor-alpha genotypes in rheumatoid arthritis--association with clinical response to glucocorticoids.
    de Paz B; Alperi-López M; Ballina-García FJ; Prado C; Mozo L; Gutiérrez C; Suárez A
    J Rheumatol; 2010 Mar; 37(3):503-11. PubMed ID: 20080912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia.
    Nückel H; Collins CH; Frey UH; Sellmann L; Dürig J; Siffert W; Dührsen U
    Eur J Haematol; 2009 Dec; 83(6):541-9. PubMed ID: 19682311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGHV3-21 gene expression in patients with B-cell chronic lymphocytic leukemia in Ukraine.
    Abramenko I; Bilous N; Kryachok I; Filonenko I; Pilipenko G; Chumak A; Bazyka D; Bebeshko V
    Exp Oncol; 2007 Sep; 29(3):226-30. PubMed ID: 18004251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia.
    Visco C; Moretta F; Falisi E; Facco M; Maura F; Novella E; Nichele I; Finotto S; Giaretta I; Ave E; Perbellini O; Guercini N; Scupoli MT; Trentin L; Trimarco V; Neri A; Semenzato G; Rodeghiero F; Pizzolo G; Ambrosetti A
    Am J Hematol; 2013 Apr; 88(4):277-82. PubMed ID: 23450508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGHV3-21 gene usage is associated with high TCL1 expression in chronic lymphocytic leukemia.
    Mansouri MR; Sevov M; Aleskog A; Jondal M; Merup M; Sundström C; Osorio L; Rosenquist R
    Eur J Haematol; 2010 Feb; 84(2):109-16. PubMed ID: 19889012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults.
    Erikstrup C; Kallestrup P; Zinyama-Gutsire RB; Gomo E; Butterworth AE; Pedersen BK; Ostrowski SR; Gerstoft J; Ullum H
    AIDS; 2007 Nov; 21(17):2283-91. PubMed ID: 18090276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment.
    López P; Gómez J; Prado C; Gutiérrez C; Suárez A
    J Rheumatol; 2008 Aug; 35(8):1559-66. PubMed ID: 18597405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between tumor necrosis factor genetic polymorphisms and acute lymphocytic leukemia].
    Zhao HY; Chen YX; Lin XB; Zhong XY; Zhong LY; Ou RM; Jiang WQ; Guan ZZ
    Ai Zheng; 2003 Aug; 22(8):861-6. PubMed ID: 12917036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF-alpha-, TNF-beta-, IL-6-, and IL-10-promoter polymorphisms in patients with chronic obstructive pulmonary disease.
    Seifart C; Dempfle A; Plagens A; Seifart U; Clostermann U; Müller B; Vogelmeier C; von Wichert P
    Tissue Antigens; 2005 Jan; 65(1):93-100. PubMed ID: 15663746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic association of interleukin-10 promoter polymorphisms and susceptibility to diffuse large B-cell lymphoma: a meta-analysis.
    Cao HY; Zou P; Zhou H
    Gene; 2013 May; 519(2):288-94. PubMed ID: 23485354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia.
    Hojjat-Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Mellstedt H; Shokri F; Rabbani H
    Cancer Sci; 2009 Dec; 100(12):2346-53. PubMed ID: 19824994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.
    Rossi D; Sozzi E; Puma A; De Paoli L; Rasi S; Spina V; Gozzetti A; Tassi M; Cencini E; Raspadori D; Pinto V; Bertoni F; Gattei V; Lauria F; Gaidano G; Forconi F
    Br J Haematol; 2009 Jun; 146(1):64-75. PubMed ID: 19438485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of interleukin-10 polymorphisms (-1082 and -3575) on the survival of patients with lymphoid neoplasms.
    Domingo-Domènech E; Benavente Y; González-Barca E; Montalban C; Gumà J; Bosch R; Wang SS; Lan Q; Whitby D; Fernández de Sevilla A; Rothman N; de Sanjosé S
    Haematologica; 2007 Nov; 92(11):1475-81. PubMed ID: 18024395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of interferon-gamma, interleukin-10, and tumor necrosis factor-alpha gene polymorphisms with occurrence and severity of Eales' disease.
    Sen A; Paine SK; Chowdhury IH; Mondal LK; Mukherjee A; Biswas A; Chowdhury S; Bhattacharya S; Bhattacharya B
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):171-8. PubMed ID: 20720222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of TNF-alpha, TGF-beta 1, IL-10, IL-6, IFN-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic thrombocytopenic purpura.
    Pehlivan M; Okan V; Sever T; Balci SO; Yilmaz M; Babacan T; Pehlıvan S
    Platelets; 2011; 22(8):588-95. PubMed ID: 21591983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.